1 | Study | 1.71% | |
2 | Health | 1.19% | |
3 | Case | 0.96% | |
4 | Cancer | 0.89% | |
5 | Report | 0.86% | |
6 | Disease | 0.69% | |
7 | Patients | 0.59% | |
8 | HIV | 0.59% | |
9 | Risk | 0.49% | |
10 | New | 0.49% | |
11 | May | 0.46% | |
12 | Diabetes | 0.46% | |
13 | Heart | 0.46% | |
14 | Patient | 0.43% | |
15 | FDA | 0.36% | |
16 | AI | 0.36% | |
17 | Use | 0.36% | |
18 | Review | 0.33% | |
19 | Brain | 0.33% | |
20 | Therapy | 0.33% | |
21 | Drug | 0.3% | |
22 | Treatment | 0.3% | |
23 | Linked | 0.3% | |
24 | First | 0.3% | |
25 | Failure | 0.26% | |
26 | Elderly | 0.26% | |
27 | UK | 0.26% | |
28 | Africa | 0.26% | |
29 | Pediatric | 0.26% | |
30 | Type | 0.23% | |
31 | Researchers | 0.23% | |
32 | Chronic | 0.23% | |
33 | Research | 0.23% | |
34 | Weight | 0.23% | |
35 | Women | 0.23% | |
36 | Blood | 0.23% | |
37 | Liver | 0.23% | |
38 | Care | 0.23% | |
39 | Screening | 0.2% | |
40 | Among | 0.2% | |
41 | Management | 0.2% | |
42 | Vaccine | 0.2% | |
43 | Response | 0.2% | |
44 | Mortality | 0.2% | |
45 | Clinical | 0.2% | |
46 | Diagnosis | 0.2% | |
47 | Technology | 0.2% | |
48 | GLP-1 | 0.2% | |
49 | Higher | 0.2% | |
50 | NHS | 0.2% | |
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
Weight-Loss Supplements: What Physicians Should Know About Safety, Efficacy, and Counseling Patients
Medscape
2025-06-10 20:28:28
Comparative Efficacy of Various Acupuncture-Related Therapies for Post | NSS
Dove Medical Press
2025-06-09 21:03:04
The efficacy of high-quality HAART in mitigating new HIV infections: a | IDR
Dove Medical Press
2025-06-09 17:52:33